Treatment of massive cerebral infarction

Current Neurology and Neuroscience Reports

Volumn 5, Issue 6, 2005, Pages 494-502

  Palestrant, David ^a   Frontera, Jennifer A ^a   Mayer, Stephan A ^a  

^a NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTICONVULSIVE AGENT; BUSPIRONE; DEXMEDETOMIDINE; DOPAMINE; FENTANYL; FIBRINOLYTIC AGENT; HEPARIN; INSULIN; LABETALOL; LOW MOLECULAR WEIGHT HEPARIN; MANNITOL; NICARDIPINE; NORADRENALIN; OSMOTIC AGENT; PARACETAMOL; PETHIDINE; PHENYLEPHRINE; PROPOFOL; SODIUM CHLORIDE; UROKINASE;

BLEEDING; BLOOD CLOTTING DISORDER; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE REGULATION; BRADYCARDIA; BRAIN DECOMPRESSION; BRAIN DISEASE; BRAIN EDEMA; BRAIN INFARCTION; BRAIN ISCHEMIA; CAUSE OF DEATH; CLINICAL PROTOCOL; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CRANIECTOMY; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DISEASE SEVERITY; DOSE RESPONSE; DRUG HYPERSENSITIVITY; DRUG MECHANISM; ELECTROLYTE DISTURBANCE; EMERGENCY TREATMENT; HEART ARRHYTHMIA; HEART EDEMA; HEART INFARCTION; HEMOLYSIS; HUMAN; HYPERCHLOREMIC ACIDOSIS; HYPERGLYCEMIA; HYPERTENSION; HYPOGLYCEMIA; HYPOKALEMIA; INDUCED HYPOTHERMIA; INTENSIVE CARE UNIT; KIDNEY FAILURE; LUNG EDEMA; META ANALYSIS; MORBIDITY; MORTALITY; NONHUMAN; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PHLEBITIS; REVIEW; SEIZURE; SHIVERING; SIDE EFFECT; STROKE; SYSTEMATIC REVIEW; TACHYCARDIA; THROMBOCYTE AGGREGATION; VASOCONSTRICTION;

EID: 28244458057     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-005-0040-1     Document Type: Review

References (80)

1. American Heart Association: Heart Disease and Stroke Statistics - update 2005. http://wwwstrokeassociationorg. Accessed on March 7, 2005.
2. Hacke W, Schwab S, Horn M, et al.: 'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 1996, 53:309-315.
3. Aiyagari VD, Michael N: Management of large hemispheric strokes in the neurological intensive care unit. Neurologist 2002, 8:152-162.
4. Wijman CA: Editorial comment - can we predict massive space-occupying edema in large hemispheric infarctions? Stroke 2003, 34:1899-1900.
5. Henderson GV: Management of massive cerebral infarct. Curr Neurol Neurosci Rep 2004, 4:497-504.
6. Krieger DW, Demchuk AM, Kasner SE, et al.: Early clinical and radiological predictors of fatal brain swelling in ischemic stroke. Stroke 1999, 30:287-292.
7. Oppenheim C, Samson Y, Manai R, et al.: Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging. Stroke 2000, 31:2175-2181.
8. Thomalla GJ, Kucinski T, Schoder V, et al.: Prediction of malignant middle cerebral artery infarction by early perfusion- and diffusion-weighted magnetic resonance imaging. Stroke 2003, 34:1892-1899.
9. Ronning OM, Guldvog B, Stavem K: The benefit of an acute stroke unit in patients with intracranial haemorrhage: a controlled trial. J Neurol Neurosurg Psychiatry 2001, 70:631-634.
10. Douglas VC, Tong DC, Gillum LA, et al.: Do the Brain Attack Coalition's criteria for stroke centers improve care for ischemic stroke? Neurology 2005, 64:422-427.
11. Dion JE: Management of ischemic stroke in the next decade: stroke centers of excellence. J Vasc Interv Radiol 2004, 15(1 Pt 2): S133-S141.
12. Adams HP Jr, Adams RJ, Brott T, et al.: Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003, 34:1056-1083.
13. Adams H, Adams R, Del Zoppo G, et al.: Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 2005, 36:916-923.
14. Brott T, Bogousslavsky J: Treatment of acute ischemic stroke. N Engl J Med 2000, 343:710-722.
15. Verstappen A, Thijs V: What do we (not) know about the management of blood pressure in acute stroke? Curr Neurol Neurosci Rep 2004, 4:505-509.
16. Novak V, Chowdhary A, Farrar B, et al.: Altered cerebral vasoregulation in hypertension and stroke. Neurology 2003, 60:1657-1663.
17. Hillis AE, Barker PB, Beauchamp NJ, et al.: Restoring blood pressure reperfused Wernicke's area and improved language. Neurology 2001, 56:670-672.
18. Hillis AE, Ulatowski JA, Barker PB, et al.: A pilot randomized trial of induced blood pressure elevation: effects on function and focal perfusion in acute and subacute stroke. Cerebrovasc Dis 2003, 16:236-246.
19. Rordorf G, Cramer SC, Efird JT, et al.: Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. Stroke 1997, 28:2133-2138.
20. Schwarz S, Georgiadis D, Aschoff A, et al.: Effects of induced hypertension on intracranial pressure and flow velocities of the middle cerebral arteries in patients with large hemispheric stroke. Stroke 2002, 33:998-1004.
21. Oliveira-Filho J, Silva SC, Trabuco CC, et al.: Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset. Neurology 2003, 61:1047-1051.
22. Williams LS, Rotich J, Qi R, et al.: Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 2002, 59:67-71.
23. Baird TA, Parsons MW, Phanh T, et al.: Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003, 34:2208-2214.
24. Bruno A, Biller J, Adams HP Jr, et al.: Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 1999, 52:280-284.
25. Bruno A, Levine SR, Frankel MR, et al.: Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002, 59:669-674.
26. Bruno A, Williams LS, Kent TA: How important is hyperglycemia during acute brain infarction? Neurologist 2004, 10:195-200.
27. Capes SE, Hunt D, Malmberg K, et al.: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001, 32:2426-2432.
28. Gray CS, Hildreth AJ, Alberti GY, et al.: Poststroke hyperglycemia: natural history and immediate management. Stroke 2004, 35:122-126.
29. Khoury W, Klausner JM, Ben-Abraham R, et al.: Glucose control by insulin for critically ill surgical patients. J Trauma 2004, 57:1132-1138.
30. van den Berghe G, Wouters P, Weekers F, et al.: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345:1359-1367.
31. van den Berghe G, Schoonheydt K, Becx P, et al.: Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005, 64:1348-1353.
32. Malmberg K, Ryden L, Efendic S, et al.: Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995, 26:57-65.
33. Pittas AG, Siegel RD, Lau J: Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Intern Med 2004, 164:2005-2011.
34. Kempski O: Hypertonic saline and stroke. Crit Care Med 2005, 33:259-260.
35. Georgiadis AL, Suarez JI: Hypertonic saline for cerebral edema. Curr Neurol Neurosci Rep 2003, 3:524-530.
36. Doyle JA, Davis DP, Hoyt DB: The use of hypertonic saline in the treatment of traumatic brain injury. J Trauma 2001, 50:367-383.
37. Bhardwaj A, Ulatowski JA: Hypertonic saline solutions in brain injury. Curr Opin Crit Care 2004, 10:126-131.
38. Toung TJ, Chang Y, Lin J, et al.: Increases in lung and brain water following experimental stroke: effect of mannitol and hypertonic saline. Crit Care Med 2005, 33:203-208; discussion 259-260.
39. Toung TJ, Hurn PD, Traystman RJ, et al.: Global brain water increases after experimental focal cerebral ischemia: effect of hypertonic saline. Crit Care Med 2002, 30:644-649.
40. Bhardwaj A, Harukuni I, Murphy SJ, et al.: Hypertonic saline worsens infarct volume after transient focal ischemia in rats. Stroke 2000, 31:1694-1701.
41. Schwarz S, Schwab S, Bertram M, et al.: Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke 1998, 29:1550-1555.
42. Schwarz S, Georgiadis D, Aschoff A, et al.: Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke 2002, 33:136-140.
43. Hofmeijer J, van der Worp HB, Kappelle LJ: Treatment of space-occupying cerebral infarction. Crit Care Med 2003, 31:617-625.
44. Bereczki D, Liu M, Prado GF, et al.: Cochrane report: a systematic review of mannitol therapy for acute ischemic stroke and cerebral parenchymal hemorrhage. Stroke 2000, 31:2719-2722.
45. Schrot RJ, Muizelaar JP: Mannitol in acute traumatic brain injury. Lancet 2002, 359:1633-1634.
46. Manno EM, Adams RE, Derdeyn CP, et al.: The effects of mannitol on cerebral edema after large hemispheric cerebral infarct. Neurology 1999, 52:583-587.
47. Videen TO, Zazulia AR, Manno EM, et al.: Mannitol bolus preferentially shrinks non-infarcted brain in patients with ischemic stroke. Neurology 2001, 57:2120-2122.
48. Kaufmann AM, Cardoso ER: Aggravation of vasogenic cerebral edema by multiple-dose mannitol. J Neurosurg 1992, 77:584-589.
49. Gupta R, Connolly ES, Mayer S, et al.: Hemicraniectomy for massive middle cerebral artery territory infarction: a systematic review. Stroke 2004, 35:539-543.
50. Curry WT Jr, Sethi MK, Ogilvy CS, et al.: Factors associated with outcome after hemicraniectomy for large middle cerebral artery territory infarction. Neurosurgery 2005, 56:681-692; discussion 681-692.
51. Uhl E, Kreth FW, Elias B, et al.: Outcome and prognostic factors of hemicraniectomy for space occupying cerebral infarction. J Neurol Neurosurg Psychiatry 2004, 75:270-274.
52. Kastrau F, Wolter M, Huber W, et al.: Recovery from aphasia after hemicraniectomy for infarction of the speech-dominant hemisphere. Stroke 2005, 36:825-829.
53. Georgiadis D, Schwarz S, Aschoff A, et al.: Hemicraniectomy and moderate hypothermia in patients with severe ischemic stroke. Stroke 2002, 33:1584-1588.
54. Original Website: strokecenter.org, Stroke Trials directory. http://www.strokecenter.org/trials/.Accessed September 15, 2005.
55. Kase CS, Norrving B, Levine SR, et al.: Cerebellar infarction. Clinical and anatomic observations in 66 cases. Stroke 1993, 24:76-83.
56. Macdonell RA, Kalnins RM, Donnan GA: Cerebellar infarction: natural history, prognosis, and pathology. Stroke 1987, 18:849-855.
57. Kirollos RW, Tyagi AK, Ross SA, et al.: Management of spontaneous cerebellar hematomas: a prospective treatment protocol. Neurosurgery 2001, 49:1378-1386; discussion 1386-1377.
58. Jensen MB, St Louis EK: Management of acute cerebellar stroke. Arch Neurol 2005, 62:537-544.
59. Georgiadis D, Schwab S: Hypothermia in Acute Stroke. Curr Treat Options Neurol 2005, 7:119-127.
60. Krieger DW, Yenari MA: Therapeutic hypothermia for acute ischemic stroke: what do laboratory studies teach us? Stroke 2004, 35:1482-1489.
61. Kollmar R, Schabitz WR, Heiland S, et al.: Neuroprotective effect of delayed moderate hypothermia after focal cerebral ischemia: an MRI study. Stroke 2002, 33:1899-1904.
62. Bernard SA, Buist M: Induced hypothermia in critical care medicine: a review. Crit Care Med 2003, 31:2041-2051.
63. The Hypothermia After Cardiac Arrest Study Group: Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002, 346:549-556.
64. Bernard SA, Gray TW, Buist MD, et al.: Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002, 346:557-563.
65. Schwab S, Georgiadis D, Berrouschot J, et al.: Feasibility and safety of moderate hypothermia after massive hemispheric infarction. Stroke 2001, 32:2033-2035.
66. Schwab S, Schwarz S, Spranger M, et al.: Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke 1998, 29:2461-2466.
67. Krieger DW, De Georgia MA, Abou-Chebl A, et al.: Cooling for acute ischemic brain damage (cool aid): an open pilot study of induced hypothermia in acute ischemic stroke. Stroke 2001, 32:1847-1854.
68. De Georgia MA, Krieger DW, Abou-Chebl A, et al.: Cooling for Acute Ischemic Brain Damage (COOL AID): a feasibility trial of endovascular cooling. Neurology 2004, 63:312-317.
69. Georgiadis D, Schwarz S, Kollmar R, et al.: Endovascular cooling for moderate hypothermia in patients with acute stroke: first results of a novel approach. Stroke 2001, 32:2550-2553.
70. Clifton GL, Miller ER, Choi SC, et al.: Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med 2001, 344:556-563.
71. Hajat C, Hajat S, Sharma P: Effects of poststroke pyrexia on stroke outcome: a meta-analysis of studies in patients. Stroke 2000, 31:410-414.
72. Marion DW: Controlled normothermia in neurologic intensive care. Crit Care Med 2004, 32(Suppl 2):S43-S45.
73. Berges S, Moulin T, Berger E, et al.: Seizures and epilepsy following strokes: recurrence factors. Eur Neurol 2000, 43:3-8.
74. Lamy C, Domigo V, Semah F, et al.: Early and late seizures after cryptogenic ischemic stroke in young adults. Neurology 2003, 60:400-404.
75. So EL, Annegers JF, Hauser WA, et al.: Population-based study of seizure disorders after cerebral infarction. Neurology 1996, 46:350-355.
76. Goldstein LB: Common drugs may influence motor recovery after stroke. The Sygen in Acute Stroke Study Investigators. Neurology 1995, 45:865-871.
77. The International Stroke Trial (IST): a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 1997, 349:1569-1581.
78. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. JAMA 1998, 279:1265-1272.
79. Mazzone C, Chiodo GF, Sandercock P, et al.: Physical methods for preventing deep vein thrombosis in stroke. Cochrane Database Syst Rev 2004:CD001922.
80. Coull BM, Williams LS, Goldstein LB, et al.: Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). Stroke 2002, 33:1934-1942.